As of May 29
| +0.45 / +0.63%|
The 13 analysts offering 12-month price forecasts for DexCom Inc have a median target of 74.00, with a high estimate of 81.00 and a low estimate of 39.00. The median estimate represents a +3.18% increase from the last price of 71.72.
The current consensus among 15 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.